Mortgage Blog
Opinion: Giving strategies should include donor advised funds, despite controversies
When giving to charities, DAFs are a method to consider.
Flagship-backed startup Evelo, behind failed eczema drug, to dissolve
The Cambridge biotech that held two rounds of layoffs earlier this year is shutting down for good.
What Novant Health execs made in 2022: CEO gets nearly 19% raise
Despite upper-level and executive layoffs in 2023, Novant Health's leader received a 19% increase in compensation in 2022. We've got the details on what all members of the executive team earned, including of the CFO who departed two months ago and of an executive officer whose salary increased 41% between 2021 and 2022.
Union nurses at St. Francis, St. Joseph will strike against ‘unsafe conditions’
It will be the second time St. Francis nurses have gone on strike. Hundreds of RNs were at the picket lines in June.
Endo International creditors offer federal agencies up to $465M to clear way for sale
The proposal includes an option for the federal government to accept a $200 million lump sum payment.
pH-D Feminine Health, one of Nashville’s largest women-owned businesses, poised for growth
PH-D Feminine Health is set for more growth in 2024. The company is growing in revenue and store presence across the country — plus looking to expand its employee count and office space.
Penn spinout Vivodyne raises $38M to advance platform making lab-grown human organs for new drug testing
Vivodyne's platform is designed to improve the discovery and development of drug candidates by testing them — using robots — directly on thousands of lifelike, lab-grown human organ tissues simultaneously.
Entrada shares slide as FDA maintains freeze on Duchenne drug
Entrada Therapeutics Inc. won't be able to start testing a Duchenne drug in the U.S. anytime soon, based on new feedback from the Food and Drug Administration.
Health care technology company to lay off 99 employees in Hunt Valley
The layoffs come just a few weeks after the company was acquired by a private equity firm.
Lazydays continues national expansion despite concerns about cash
Lazydays announced the acquisition of an Arizona RV dealership a week after cancelling plans to raise $100 million to shore up cash.